Abbott Revenue


USD 111.48  0.99  0.90%   

Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Abbott Laboratories Revenue to Assets are comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Revenue to Assets of 0.57 in 2021. Revenue Per Employee is likely to gain to about 391.5 K in 2022, whereas Cost of Revenue is likely to drop slightly above 16.4 B in 2022.

Abbott Revenue Analysis

Abbott Laboratories' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Abbott Laboratories Revenues

37.89 Billion

Money Received 
Discounts and Returns 
More About Revenue | All Equity Analysis

Current Abbott Laboratories Revenue

  45.55 B  
Most of Abbott Laboratories' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Abbott Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Revenue. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.

Abbott Revenue Historical Pattern

Today, most investors in Abbott Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abbott Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abbott Laboratories revenue as a starting point in their analysis.
   Abbott Laboratories Revenue   
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Abbott Cost of Revenue

Cost of Revenue

16.44 Billion

Abbott Laboratories Cost of Revenue is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Cost of Revenue of 18.54 Billion in 2021
Based on the latest financial disclosure, Abbott Laboratories reported 45.55 B of revenue. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The revenue for all United States stocks is significantly lower than that of the firm.

Abbott Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.
Abbott Laboratories is currently under evaluation in revenue category among related companies.

Abbott Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbott Laboratories from analyzing Abbott Laboratories' financial statements. These drivers represent accounts that assess Abbott Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbott Laboratories' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee4.82 K22.99 K34.46 K41.13 K62.58 K56.09 K
Revenue Per Employee276.67 K296.87 K298.17 K316.64 K381.19 K391.53 K
Average Assets72.63 B69.53 B68.12 B69.29 B73.76 B72.94 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA6.28 B7.01 B7.76 B8.87 B12.28 B10.6 B
Earnings Before Interest Taxes and Depreciation Amortization USD6.28 B7.01 B7.76 B8.87 B12.28 B10.6 B
Earnings before Tax2.35 B2.91 B4.08 B4.99 B8.21 B6.71 B
Average Equity31.66 B31 B31.59 B31.46 B34.62 B34.04 B
Enterprise Value112.35 B143.22 B168.61 B208.14 B257.96 B207.34 B
Free Cash Flow4.43 B4.91 B4.5 B5.72 B8.65 B7.28 B
Invested Capital40.16 B31.45 B30.8 B33.71 B34.37 B35.08 B
Invested Capital Average38.38 B32.91 B32.55 B33.39 B33.57 B33.94 B
Market Capitalization99.34 B127.04 B153.61 B194.06 B248.87 B197.54 B
Tangible Asset Value30.76 B24.98 B27.67 B34.02 B39.23 B34.16 B
Working Capital11.23 B5.62 B4.8 B8.53 B11.13 B9.9 B

Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Abbott Fundamentals

About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Cost of Revenue18.5 B16.4 B
Revenues43.1 B37.9 B
Revenue to Assets 0.57  0.59 
Revenue Per Employee381.2 K391.5 K
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now


Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
193.5 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.